Endocrine, Diabetes, Osteoporosis Flashcards

(44 cards)

1
Q

Hyperthyroidism - symptomatic treatment (tachycardia, arrhythmia, angina, tremor, agitation )

A

Propanolol

Beta blocker - DONT use with Ca channel blocker verapamil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hyperthyroidism - prolonged, or short term before surgery

A

Carbimazole, thionamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hyperthyroidism - Grave’s disease

A

Carbimazole, thionamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hyperthyroidism - short term for throtoxic criss, prep for thyroidectomy

A

Iodine/ iodide supplement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hyperthyroidism and thyroid carcinoma

A

Radioactive iodine - not for pregnant ladies.

Side note, low iodine for pregnant female, results in baby with cretinism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hypothyroidism drug of choice

A

T4 - thyroxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypothyroidism treatment 2 drugs

A

T4 thyroxine

T3 triiodothyronine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Medicines that weaken bone

A
Glucocorticoids (prednisolone)
thyroid hormone
heparin 
antiepileptic drugs
glitazones 
aromatase inhibitors (anastrazole)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Osteoporosis - preventative treatment

A

Calcitriol (Vit D)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Osteoporosis - what drug is not generally recommended for use to prevent bone loss or fractures

A

Hormone replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Osteoporosis - what drug has beneficial effects on the bone without effect on other tissues?

A

Raloxifene

Selective estrogen receptor modulator (SERM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Osteoporosis - what drug is 1st line management for post menopausal osteoporosis?

A

Alendronate - a biphosphate.

DO NOT take with glucocorticoids, due to increased risk of atypical fractures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Biphosphate alendronate what are three main side effects -

and why low compliance?

A
  1. Oesophagitis
  2. Atypical fractures
  3. Osteonecrotising Jaw

Take in morning before breakfast, remain standing for thirty minutes afterwards.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Osteoporosis - what do you give if biphosphate are unsuitable?

A

Densumab - monoclonal antibody against RANKL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What’s the relationship between RANKL, RANK and OPG

A

RANK Ligand found on osteoblasts - activate RANK found on osteoclast progenitors. OPG (osteoprotegerin) act as antibodies against RANKL inhibiting osteoclast activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Osteoporosis drug with low efficacy

A

Calcitonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Osteoporosis drug of choice when there is a high risk of fractures or other treatments are unsuitable.

A

Teriparatide (PTH/PTH fragments), anabolic bone agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diabetes drug - take immediately before a meal

A

Insulin lispro, insulin aspart, ultra short acting insulin

19
Q

Diabetes - IV in hyperglycaemic emergency or before a meal.

A

Soluble insulin (neutral), short acting insulin

20
Q

Diabetes - combine with short acting and give twice a day (mimics basal release)

A

Isophane - intermediate acting insulin

21
Q

Diabetes- give AT BREAKFAST with short acting given at meals (mimics basal release)

A

Ultralente Long acting insulin

22
Q

Diabetes - first choice sensitising agent unless renal problems

A

Metformin - insulin sensitisor

23
Q

Diabetes - less efficacious than metformin or sulphonureas

A

Thiazolidinediones

TZDs/glitazones, insulin sensitiser

24
Q

Diabetes - useful in early stages of diabetes

A

Glicazides

Sulphonylureas - insulin secretion

25
Diabetes - may be used in patients with allergy to sulphonylureas
Repaglinide - glitinide. | Insulin secretion
26
Diabetes- usual when postprandial BG remains high despite dietary modification
Acarbose A-glucosidase inhibitor Oral hypoglycaemic agent
27
Propanolol BB S/E
Bronchoconstriction, bradycardia, AV block, depression, sedation, exacerbate diabetes, mask hypoglycaemia, impotence
28
Carbimazole - thionamide S/E
Agranulocytosis, cross placenta and milk, rashes, headache, nausea, joint pain
29
Iodine/iodide supplement S/E
possible allergic reactions.
30
Radioactive iodine S/E
Hypothyroidism, thyroid cancer (small increase in risk)
31
T4 (thyroxine) S/E
Elderly at risk of angina, arrhythmia, heart failure, osteoporosis
32
Calcitriol (Vit D) S/E
Hypercalcaemia, hypercalciuria
33
Hormone Replacement Therapy S/E
Increased risk of cancers (breast), adverse cardiovascular effects
34
Raloxifene (Selective estrogen receptor modulator SERM) S/E
May affect breast and endometrial tissue, adverse cardiovascular effects
35
Alendronate (Biphosphate) - S/E
Osteonecrosis of jaw, effect limited after 5 years, GI effects, compliance issues, atypical fractures
36
Densumab (Monoclonal Antibody RANKL) - S/E
Lacks long term safety and efficacy data
37
Teriparatide (PTH/PTH fragments bone anabolic agent) - S/E
Possible increase in osteosarcoma, stopped after 18 months
38
Insulin - all duration - S/E
Hypoglycaemia, formation of antibodies, local allergic reactions
39
Metformin - insulin sensitiser - S/E
Weight loss, nausea, diarrhoea
40
Thiazolidinediones (glitazone, insulin sensitiser) S/E
Weight gain, long term safety still unsure
41
Glicazide - sulphonylureas insulin secretion - S/E
Hight protein binding, hypoglycaemia, weight gain (stimulate appetite)
42
Repaglinide - glitinide insulin secretion - S/E
Hypoglycamia
43
Acarbose - A-glucosidase inhibitor - S/E
Flatulence diarrhoea
44
Hyperaldosteronism; often used with thiazides or loop diuretics to prevent hypokalaemia, resistant hypertension, CHF
Spironolactone Aldosterone receptor antagonist (K+ sparing)